from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2497c/bkdA

LFCtreatmentdescriptionclass of inhibitor

-0.215

Amikacinug/mL Amikacintranslation

-0.278

Cap5-10ug/mL Capreomycintranslation

-0.101

Rox10-50 ug/mL Roxithromycintranslation

-0.608

SM2-5 ug/mL Streptomycintranslation

-0.001

Tet5-10 ug/mL Tetracyclinetranslation

0.026

Rif0.2-5ug/mL Rifampicintranscription

-0.730

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.182

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.833

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.032

CPZ10-50 ug/mL Chlorpromazinerespiration

0.005

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.793

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

3.599

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.416

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.462

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.907

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.270

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.429

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.606

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.162

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.729

KCN5-20 ug/mL Potassium cyaniderespiration

0.024

NaN30.2-2 mM Sodium aziderespiration

0.557

Nigericin50 uM Nigericinrespiration

1.232

TRC10-150 ug/mL Triclosanrespiration

0.585

TRZ10-25 ug/mL Thioridazinerespiration

0.969

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.183

menadione6-10 ug/mL Menadionerespiration

-0.628

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.673

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.800

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.259

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.774

NRP_1Non-replicating persistence stage 1dosRassociated

-0.322

Amp0.2mg/mL AmpicillincellWall

-0.548

Cephalexin20-100 ug/mL CephalexincellWall

-0.455

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.299

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.206

EMB10-20 ug/mL EthambutolcellWall

-0.172

Eta12-40 ug/mL EthionamidecellWall

-0.293

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.272

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.288

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.366

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.801

BZA0.12 mg/mL BenzamidearomaticAmides

0.664

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.757

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.386

H2O24 mM hydrogen peroxideDNAdamaging

-0.860

Levo10 ug/mL LevofloxacinDNAdamaging

-0.762

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.572

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.716

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.815

UVUV-irradiationDNAdamaging

1.058

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.800

Antimycin12.5-50 ug/mL Antimycin A?

-0.876

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.315

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.654

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.407

PA8240.2-2 ug/mL PA-824?

1.909

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.250

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.898

Verapamil50 uM Verapamil?

-0.756

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.167

methoxatin10-20 ug/mL Methoxatin?